Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Apellis Pharmaceuticals News
APLS
APELLIS PHARMACEUTICALS INC
35.41
+1.23%
APLS
APELLIS PHARMACEUTICALS INC
35.41
+1.23%
Articles
Latest stories
Coherus Sells Humira Biosimilar Yusimry for $40M; CHMP Issues Negative Opinions on PTC and Apellis Drugs
Authors
8
6 days
Europe
Economics
Bio
Apellis Pharmaceuticals' Empaveli and Syfovre Face European Approval Jeopardy with 14% Stock Slide
Authors
4
7 months
Economics
Business
Previous
Next